Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Gastric Cancer

Free Subscription Articles published in Gut Retrieve available abstracts of 52 articles: HTML format

Single Articles

August 2026
1. LENTI MV, DiPaolo RJ, Di Sabatino A, Camargo MC, et al
   Autoimmune gastritis: a hidden gateway to cardia and oesophageal cancers beyond non-cardia gastric adenocarcinoma.
   Gut. 2026;75:1845-1856.
   PubMed     Abstract available
   
   
   
2. ZHENG J, Li Y, Fan L, Zheng C, et al
   Prospective evaluation of radical surgery for adenocarcinoma of oesophagogastric junction: real-world insights from the CLAEG study.
   Gut. 2026;75:1726-1738.
   PubMed     Abstract available
   
   
   July 2026
3. CHEN Q, Zhang L, Chen B, Li M, et al
   Macropinocytosis of neutrophil extracellular trap by gastric cancer cells promotes immune escape and peritoneal metastasis.
   Gut. 2026 Jul 28:gutjnl-2026-338485. doi: 10.1136/gutjnl-2026-338485.
   PubMed     Abstract available
   
   
   April 2026
4. GAO J, Lau HC, Fuhler GM, Yu J, et al
   Gastric microbiota-mediated immune remodelling in gastric cancer.
   Gut. 2026 Apr 22:gutjnl-2026-338505. doi: 10.1136/gutjnl-2026-338505.
   PubMed     Abstract available
   
   
   February 2026
5. DECOURTYE-ESPIARD L, Schulpen E, McElroy K, Charlton A, et al
   E-cadherin loss in Cd44-positive gastric cells initiates diffuse gastric cancer in a murine model.
   Gut. 2026 Feb 18:gutjnl-2025-336182. doi: 10.1136/gutjnl-2025-336182.
   PubMed     Abstract available
   
   
   
6. YANG Y, Yang R, Chen Y, He C, et al
   Acinetobacter baumannii promotes gastric cancer metastasis via NA-mediated NAD metabolism reprogramming and glycolytic activation.
   Gut. 2026 Feb 9:gutjnl-2025-336161. doi: 10.1136/gutjnl-2025-336161.
   PubMed     Abstract available
   
   
   January 2026
7. CHANG YH, Hong TC, Lin KT, Hsiao YJ, et al
   Integrative proteogenomics maps multifactorial aetiology, progression and therapeutic vulnerabilities in gastric cancer.
   Gut. 2026 Jan 30:gutjnl-2025-337247. doi: 10.1136/gutjnl-2025-337247.
   PubMed     Abstract available
   
   
   
8. COLLATUZZO G, Camargo MC, Malvezzi M, Dajti E, et al
   Gastric cancer attributable to Helicobacter pylori in 2040.
   Gut. 2026 Jan 28:gutjnl-2025-337499. doi: 10.1136/gutjnl-2025-337499.
   PubMed    
   
   
   
9. ZHOU CB, Zhao LC, Qin Y, Yu J, et al
   Streptococcus anginosus-derived methionine promotes gastric cancer progression.
   Gut. 2026 Jan 2:gutjnl-2025-336966. doi: 10.1136/gutjnl-2025-336966.
   PubMed     Abstract available
   
   
   December 2025
10. BANG JY, Puri R, Lakhtakia S, Thakkar S, et al
    Endoscopic or surgical gastroenterostomy for malignant gastric outlet obstruction: a randomised trial.
    Gut. 2025;75:24-32.
    PubMed     Abstract available
    
    
    
11. KIM H, Kim J, Jeong IH, Park E, et al
    Hybrid identity and distinct methylation profiles of incomplete intestinal metaplasia in the stomach.
    Gut. 2025;75:10-23.
    PubMed     Abstract available
    
    
    November 2025
12. JONES CM, Ng WH, Tincknell L, McClurg DP, et al
    Research priorities for cancers of the oesophagus and stomach: recommendations from a UK and Ireland patient and healthcare professional partnership exercise.
    Gut. 2025;74:1949-1961.
    PubMed     Abstract available
    
    
    October 2025
13. SHENG T, Sundar R, Srivastava S, Ong X, et al
    Spatial profiling of patient-matched HER2 positive gastric cancer reveals resistance mechanisms to targeted therapy.
    Gut. 2025 Oct 30:gutjnl-2024-334667. doi: 10.1136/gutjnl-2024-334667.
    PubMed     Abstract available
    
    
    
14. WANG K, Xie CJ, Ding Z, Shan T, et al
    PDE5A(+) cancer-associated fibroblasts enhance immune suppression in gastric cancer.
    Gut. 2025 Oct 20:gutjnl-2025-335794. doi: 10.1136/gutjnl-2025-335794.
    PubMed     Abstract available
    
    
    
15. LEUNG WK, Ang TL, Shah S, Cheung KS, et al
    Asian Pacific Association of Gastroenterology task force recommendations on surveillance for Helicobacter pylori associated gastric premalignant conditions.
    Gut. 2025 Oct 7:gutjnl-2025-335823. doi: 10.1136/gutjnl-2025-335823.
    PubMed     Abstract available
    
    
    September 2025
16. LOBO S, Dias A, Pedro AM, Ferreira M, et al
    Hereditary diffuse gastric cancer spectrum associated with germline CTNNA1 loss of function revealed by clinical and molecular data from 351 carrier families and over 37 000 non-carrier controls.
    Gut. 2025 Sep 25:gutjnl-2024-334601. doi: 10.1136/gutjnl-2024-334601.
    PubMed     Abstract available
    
    
    
17. LIOU JM, Malfertheiner P, Hong TC, Cheng HC, et al
    Screening and eradication of Helicobacter pylori for gastric cancer prevention: Taipei Global Consensus II.
    Gut. 2025 Sep 5:gutjnl-2025-336027. doi: 10.1136/gutjnl-2025-336027.
    PubMed     Abstract available
    
    
    June 2025
18. TOGASAKI K, Sato T
    Decoding intestinal metaplasia: a step towards understanding gastric tumourigenesis.
    Gut. 2025 Jun 20:gutjnl-2024-334234. doi: 10.1136/gutjnl-2024-334234.
    PubMed    
    
    
    
19. HUANG W, Li Y, Li J
    Enhancing non-invasive early detection of gastric cancer: a critical reflection on exosome ncRNA and machine learning.
    Gut. 2025 Jun 19:gutjnl-2025-335183. doi: 10.1136/gutjnl-2025-335183.
    PubMed    
    
    
    
20. 
    Retraction: Unleashing the potential of exosome ncRNAs for early gastric cancer detection-a critical appraisal of machine learning approaches.
    Gut. 2025 Jun 17:gutjnl-2025-334909.ret. doi: 10.1136/gutjnl-2025-334909.
    PubMed    
    
    
    April 2025
21. LEE YC
    Single-biopsy epigenetic profiling reveals persistent DNA methylation and gastric cancer risk after Helicobacter pylori eradication.
    Gut. 2025 Apr 23:gutjnl-2025-335329. doi: 10.1136/gutjnl-2025-335329.
    PubMed    
    
    
    
22. YAMADA H, Abe S, Charvat H, Ando T, et al
    Precision risk stratification of primary gastric cancer after eradication of H. pylori by a DNA methylation marker: a multicentre prospective study.
    Gut. 2025 Apr 15:gutjnl-2025-335039. doi: 10.1136/gutjnl-2025-335039.
    PubMed     Abstract available
    
    
    
23. KEMP LJS, Monster JL, Wood CS, Moers M, et al
    Tumour-intrinsic alterations and stromal matrix remodelling promote Wnt-niche independence during diffuse-type gastric cancer progression.
    Gut. 2025 Apr 1:gutjnl-2024-334589. doi: 10.1136/gutjnl-2024-334589.
    PubMed     Abstract available
    
    
    March 2025
24. GUO X, Wang W, Cheng X, Song Q, et al
    Diagnostic efficacy of an extracellular vesicle-derived lncRNA-based liquid biopsy signature for the early detection of early-onset gastric cancer.
    Gut. 2025 Mar 20:gutjnl-2024-333657. doi: 10.1136/gutjnl-2024-333657.
    PubMed     Abstract available
    
    
    
25. YUE SSK, Tong Y, Siu HC, Ho SL, et al
    Divergent lineage trajectories and genetic landscapes in human gastric intestinal metaplasia organoids associated with early neoplastic progression.
    Gut. 2025;74:522-538.
    PubMed     Abstract available
    
    
    February 2025
26. ZENG X
    Unleashing the potential of exosome ncRNAs for early gastric cancer detection-a critical appraisal of machine learning approaches.
    Gut. 2025 Feb 23:gutjnl-2025-334909. doi: 10.1136/gutjnl-2025-334909.
    PubMed    
    
    
    
27. SHIMURA M, Matsuo J, Pang S, Jangphattananont N, et al
    IQGAP3 signalling mediates intratumoral functional heterogeneity to enhance malignant growth.
    Gut. 2025;74:364-386.
    PubMed     Abstract available
    
    
    January 2025
28. CAI ZR, Zheng YQ, Hu Y, Ma MY, et al
    Construction of exosome non-coding RNA feature for non-invasive, early detection of gastric cancer patients by machine learning: a multi-cohort study.
    Gut. 2025 Jan 3:gutjnl-2024-333522. doi: 10.1136/gutjnl-2024-333522.
    PubMed     Abstract available
    
    
    November 2024
29. LEE SH, Lee D, Choi J, Oh HJ, et al
    Spatial dissection of tumour microenvironments in gastric cancers reveals the immunosuppressive crosstalk between CCL2+ fibroblasts and STAT3-activated macrophages.
    Gut. 2024 Nov 23:gutjnl-2024-332901. doi: 10.1136/gutjnl-2024-332901.
    PubMed     Abstract available
    
    
    
30. LI Y, Zheng Y, Huang J, Nie RC, et al
    CAF-macrophage crosstalk in tumour microenvironments governs the response to immune checkpoint blockade in gastric cancer peritoneal metastases.
    Gut. 2024 Nov 12:gutjnl-2024-333617. doi: 10.1136/gutjnl-2024-333617.
    PubMed     Abstract available
    
    
    September 2024
31. DINIS-RIBEIRO M, Shah S, El-Serag H, Banks M, et al
    The road to a world-unified approach to the management of patients with gastric intestinal metaplasia: a review of current guidelines.
    Gut. 2024;73:1607-1617.
    PubMed     Abstract available
    
    
    
32. LEJA M
    Where are we with gastric cancer screening in Europe in 2024?
    Gut. 2024 Sep 4:gutjnl-2024-332705. doi: 10.1136/gutjnl-2024-332705.
    PubMed     Abstract available
    
    
    August 2024
33. BEATON DR, Sharp L, Lu L, Trudgill NJ, et al
    Diagnostic yield from symptomatic gastroscopy in the UK: British Society of Gastroenterology analysis using data from the National Endoscopy Database.
    Gut. 2024;73:1421-1430.
    PubMed     Abstract available
    
    
    July 2024
34. HUANG XB, Huang Q, Jiang MC, Zhong Q, et al
    KLHL21 suppresses gastric tumourigenesis via maintaining STAT3 signalling equilibrium in stomach homoeostasis.
    Gut. 2024 Jul 5:gutjnl-2023-331111. doi: 10.1136/gutjnl-2023-331111.
    PubMed     Abstract available
    
    
    June 2024
35. ZENG R, Gou H, Lau HCH, Yu J, et al
    Stomach microbiota in gastric cancer development and clinical implications.
    Gut. 2024 Jun 17:gutjnl-2024-332815. doi: 10.1136/gutjnl-2024-332815.
    PubMed     Abstract available
    
    
    April 2024
36. ZHANG F, Sahu V, Peng K, Wang Y, et al
    Recurrent RhoGAP gene fusion CLDN18-ARHGAP26 promotes RHOA activation and focal adhesion kinase and YAP-TEAD signalling in diffuse gastric cancer.
    Gut. 2024 Apr 15:gutjnl-2023-329686. doi: 10.1136/gutjnl-2023-329686.
    PubMed     Abstract available
    
    
    February 2024
37. RUGGE M, Genta RM, Malfertheiner P, Dinis-Ribeiro M, et al
    RE.GA.IN.: the Real-world Gastritis Initiative-updating the updates.
    Gut. 2024;73:407-441.
    PubMed     Abstract available
    
    
    January 2024
38. TAKEUCHI C, Yamashita S, Liu YY, Takeshima H, et al
    Precancerous nature of intestinal metaplasia with increased chance of conversion and accelerated DNA methylation.
    Gut. 2024;73:255-267.
    PubMed     Abstract available
    
    
    December 2023
39. LATORRE G, Silva F, Montero I, Bustamante M, et al
    Comparison of OLGA and OLGIM as predictors of gastric cancer in a Latin American population: the ECHOS Study.
    Gut. 2023 Dec 26:gutjnl-2023-331059. doi: 10.1136/gutjnl-2023-331059.
    PubMed    
    
    
    
40. MORAIS R, Libanio D, Dinis Ribeiro M, Ferreira A, et al
    Predicting residual neoplasia after a non-curative gastric ESD: validation and modification of the eCura system in the Western setting: the W-eCura score.
    Gut. 2023;73:105-117.
    PubMed     Abstract available
    
    
    
41. TAN P, Chu Y
    Single-cell profiling of gastric cardia adenocarcinoma reveals drivers of cancer stemness and therapeutic targets.
    Gut. 2023;73:1-2.
    PubMed    
    
    
    
42. WANG Z, Wang Q, Chen C, Zhao X, et al
    NNMT enriches for AQP5(+) cancer stem cells to drive malignant progression in early gastric cardia adenocarcinoma.
    Gut. 2023;73:63-77.
    PubMed     Abstract available
    
    
    November 2023
43. LAHNER E, Dilaghi E, Dottori L, Annibale B, et al
    Not all that is corpus restricted is necessarily autoimmune.
    Gut. 2023;72:2384-2385.
    PubMed    
    
    
    August 2023
44. LEJA M
    Potential of personalised approaches in gastric cancer prevention.
    Gut. 2023 Aug 27:gutjnl-2023-330215. doi: 10.1136/gutjnl-2023-330215.
    PubMed    
    
    
    July 2023
45. XU Z, Huang Y, Hu C, Du L, et al
    Efficient plasma metabolic fingerprinting as a novel tool for diagnosis and prognosis of gastric cancer: a large-scale, multicentre study.
    Gut. 2023 Jul 17:gutjnl-2023-330045. doi: 10.1136/gutjnl-2023-330045.
    PubMed     Abstract available
    
    
    
46. CAO LL, Lu H, Soutto M, Bhat N, et al
    Multivalent tyrosine kinase inhibition promotes T cell recruitment to immune-desert gastric cancers by restricting epithelial-mesenchymal transition via tumour-intrinsic IFN-gamma signalling.
    Gut. 2023 Jul 4:gutjnl-2022-329134. doi: 10.1136/gutjnl-2022-329134.
    PubMed     Abstract available
    
    
    May 2023
47. LEI WY, Lee JY, Chuang SL, Bair MJ, et al
    Eradicating Helicobacter pylori via (13)C-urea breath screening to prevent gastric cancer in indigenous communities: a population-based study and development of a family index-case method.
    Gut. 2023 May 17:gutjnl-2023-329871. doi: 10.1136/gutjnl-2023-329871.
    PubMed     Abstract available
    
    
    
48. ARAI J, Niikura R, Hayakawa Y, Hirata Y, et al
    Autoimmune gastritis may be less susceptible to cancer development than Helicobacter pylori-related gastritis based on histological analysis.
    Gut. 2023 May 17:gutjnl-2023-330052. doi: 10.1136/gutjnl-2023-330052.
    PubMed    
    
    
    April 2023
49. RALSER A, Dietl A, Jarosch S, Engelsberger V, et al
    Helicobacter pylori promotes colorectal carcinogenesis by deregulating intestinal immunity and inducing a mucus-degrading microbiota signature.
    Gut. 2023 Apr 4:gutjnl-2022-328075. doi: 10.1136/gutjnl-2022-328075.
    PubMed     Abstract available
    
    
    
50. FAN Y, Li Y, Yao X, Jin J, et al
    Epithelial SOX9 drives progression and metastases of gastric adenocarcinoma by promoting immunosuppressive tumour microenvironment.
    Gut. 2023;72:624-637.
    PubMed     Abstract available
    
    
    March 2023
51. XU C, Huang KK, Law JH, Chua JS, et al
    Comprehensive molecular phenotyping of ARID1A-deficient gastric cancer reveals pervasive epigenomic reprogramming and therapeutic opportunities.
    Gut. 2023 Mar 14:gutjnl-2022-328332. doi: 10.1136/gutjnl-2022-328332.
    PubMed     Abstract available
    
    
    February 2023
52. RUGGE M, Genta RM, Malfertheiner P, Graham DY, et al
    Gastric cancer risk in autoimmune gastritis: evidence versus opinion.
    Gut. 2023 Feb 27:gutjnl-2023-329618. doi: 10.1136/gutjnl-2023-329618.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Gastric Cancer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum